Cargando…

Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation

BACKGROUND: Diabetes is a public health problem worldwide. Although diabetes is a chronic and incurable disease, measures and treatments can be taken to control it and keep the patient stable. Diabetes has been the subject of extensive research, ranging from disease prevention to the use of technolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Granda Morales, Luis Fernando, Valdiviezo-Diaz, Priscila, Reátegui, Ruth, Barba-Guaman, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338420/
https://www.ncbi.nlm.nih.gov/pubmed/35838763
http://dx.doi.org/10.2196/37233
_version_ 1784759964466675712
author Granda Morales, Luis Fernando
Valdiviezo-Diaz, Priscila
Reátegui, Ruth
Barba-Guaman, Luis
author_facet Granda Morales, Luis Fernando
Valdiviezo-Diaz, Priscila
Reátegui, Ruth
Barba-Guaman, Luis
author_sort Granda Morales, Luis Fernando
collection PubMed
description BACKGROUND: Diabetes is a public health problem worldwide. Although diabetes is a chronic and incurable disease, measures and treatments can be taken to control it and keep the patient stable. Diabetes has been the subject of extensive research, ranging from disease prevention to the use of technologies for its diagnosis and control. Health institutions obtain information required for the diagnosis of diabetes through various tests, and appropriate treatment is provided according to the diagnosis. These institutions have databases with large volumes of information that can be analyzed and used in different applications such as pattern discovery and outcome prediction, which can help health personnel in making decisions about treatments or determining the appropriate prescriptions for diabetes management. OBJECTIVE: The aim of this study was to develop a drug recommendation system for patients with diabetes based on collaborative filtering and clustering techniques as a complement to the treatments given by the treating doctor. METHODS: The data set used contains information from patients with diabetes available in the University of California Irvine Machine Learning Repository. Data mining techniques were applied for processing and analysis of the data set. Unsupervised learning techniques were used for dimensionality reduction and patient clustering. Drug predictions were obtained with a user-based collaborative filtering approach, which enabled creating a patient profile that can be compared with the profiles of other patients with similar characteristics. Finally, recommendations were made considering the identified patient groups. The performance of the system was evaluated using metrics to assess the quality of the groups and the quality of the predictions and recommendations. RESULTS: Principal component analysis to reduce the dimensionality of the data showed that eight components best explained the variability of the data. We identified six groups of patients using the clustering algorithm, which were evenly distributed. These groups were identified based on the available information of patients with diabetes, and then the variation between groups was examined to predict a suitable medication for a target patient. The recommender system achieved good results in the quality of predictions with a mean squared error metric of 0.51 and accuracy in the quality of recommendations of 0.61, which is acceptable. CONCLUSIONS: This work presents a recommendation system that suggests medications according to drug information and the characteristics of patients with diabetes. Some aspects related to this disease were analyzed based on the data set used from patients with diabetes. The experimental results with clustering and prediction techniques were found to be acceptable for the recommendation process. This system can provide a novel perspective for health institutions that require technologies to support health care personnel in the management of diabetes treatment and control.
format Online
Article
Text
id pubmed-9338420
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-93384202022-07-31 Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation Granda Morales, Luis Fernando Valdiviezo-Diaz, Priscila Reátegui, Ruth Barba-Guaman, Luis J Med Internet Res Original Paper BACKGROUND: Diabetes is a public health problem worldwide. Although diabetes is a chronic and incurable disease, measures and treatments can be taken to control it and keep the patient stable. Diabetes has been the subject of extensive research, ranging from disease prevention to the use of technologies for its diagnosis and control. Health institutions obtain information required for the diagnosis of diabetes through various tests, and appropriate treatment is provided according to the diagnosis. These institutions have databases with large volumes of information that can be analyzed and used in different applications such as pattern discovery and outcome prediction, which can help health personnel in making decisions about treatments or determining the appropriate prescriptions for diabetes management. OBJECTIVE: The aim of this study was to develop a drug recommendation system for patients with diabetes based on collaborative filtering and clustering techniques as a complement to the treatments given by the treating doctor. METHODS: The data set used contains information from patients with diabetes available in the University of California Irvine Machine Learning Repository. Data mining techniques were applied for processing and analysis of the data set. Unsupervised learning techniques were used for dimensionality reduction and patient clustering. Drug predictions were obtained with a user-based collaborative filtering approach, which enabled creating a patient profile that can be compared with the profiles of other patients with similar characteristics. Finally, recommendations were made considering the identified patient groups. The performance of the system was evaluated using metrics to assess the quality of the groups and the quality of the predictions and recommendations. RESULTS: Principal component analysis to reduce the dimensionality of the data showed that eight components best explained the variability of the data. We identified six groups of patients using the clustering algorithm, which were evenly distributed. These groups were identified based on the available information of patients with diabetes, and then the variation between groups was examined to predict a suitable medication for a target patient. The recommender system achieved good results in the quality of predictions with a mean squared error metric of 0.51 and accuracy in the quality of recommendations of 0.61, which is acceptable. CONCLUSIONS: This work presents a recommendation system that suggests medications according to drug information and the characteristics of patients with diabetes. Some aspects related to this disease were analyzed based on the data set used from patients with diabetes. The experimental results with clustering and prediction techniques were found to be acceptable for the recommendation process. This system can provide a novel perspective for health institutions that require technologies to support health care personnel in the management of diabetes treatment and control. JMIR Publications 2022-07-15 /pmc/articles/PMC9338420/ /pubmed/35838763 http://dx.doi.org/10.2196/37233 Text en ©Luis Fernando Granda Morales, Priscila Valdiviezo-Diaz, Ruth Reátegui, Luis Barba-Guaman. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 15.07.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Granda Morales, Luis Fernando
Valdiviezo-Diaz, Priscila
Reátegui, Ruth
Barba-Guaman, Luis
Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation
title Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation
title_full Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation
title_fullStr Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation
title_full_unstemmed Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation
title_short Drug Recommendation System for Diabetes Using a Collaborative Filtering and Clustering Approach: Development and Performance Evaluation
title_sort drug recommendation system for diabetes using a collaborative filtering and clustering approach: development and performance evaluation
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338420/
https://www.ncbi.nlm.nih.gov/pubmed/35838763
http://dx.doi.org/10.2196/37233
work_keys_str_mv AT grandamoralesluisfernando drugrecommendationsystemfordiabetesusingacollaborativefilteringandclusteringapproachdevelopmentandperformanceevaluation
AT valdiviezodiazpriscila drugrecommendationsystemfordiabetesusingacollaborativefilteringandclusteringapproachdevelopmentandperformanceevaluation
AT reateguiruth drugrecommendationsystemfordiabetesusingacollaborativefilteringandclusteringapproachdevelopmentandperformanceevaluation
AT barbaguamanluis drugrecommendationsystemfordiabetesusingacollaborativefilteringandclusteringapproachdevelopmentandperformanceevaluation